Dr Reddys Laboratories (RDY) Treasury Shares (2018 - 2026)

Dr Reddys Laboratories has reported Treasury Shares for 1 years, with the latest figure at $2.6 million in Q1 2023.

• On a quarterly basis, Treasury Shares rose 30.82% year-over-year to -$16.5 million in Q2 2026; TTM through Jun 2026 was -$16.5 million, a 30.82% increase from a year earlier, with the FY2026 full-year figure at -$19.0 million, up 29.63% from the prior year.
• Treasury Shares was -$16.5 million for Q2 2026 at Dr Reddys Laboratories, up from -$19.9 million in the prior quarter.
• The five-year high for Treasury Shares was $2.6 million in Q1 2023, with the low at $2.6 million in Q1 2023.
• Average Treasury Shares over 5 years is -$17.1 million, with a median of -$17.0 million recorded in 2026.
• The sharpest annual moves came in 2023 and 2025: Treasury Shares jumped 35.77% in 2023, then sank 119.09% in 2025.
• Over 5 years, Treasury Shares stood at -$17.6 million in 2022, then surged by 30.94% to -$12.2 million in 2023, then increased by 13.17% to -$10.6 million in 2024, then plunged by 102.61% to -$21.4 million in 2025, then increased by 22.83% to -$16.5 million in 2026.
• The last three Treasury Shares figures came in at -$16.5 million (Q2 2026), -$19.9 million (Q1 2026), and -$21.4 million (Q4 2025), per Business Quant data.